Answers are grounded in this paper and cite their sources.
Plasma exchange is a tool used in the management of patients with ANCA-associated systematic vasculitis and Goodpasture's disease. The immune complex or protein is removed by plasma exchange and replacement fluid is used to maintain circulatory volume. The endpoint is disease control and, in conjunction with a variety of drugs, dialysis independence. This article discusses the rationale for treatment.
No takes yet. Share an insight, caveat, or question.
Karen Nagalingam (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: